TY - JOUR
T1 - Conversion of human fibroblasts to angioblast-like progenitor cells
AU - Kurian, Leo
AU - Sancho-Martinez, Ignacio
AU - Nivet, Emmanuel
AU - Aguirre, Aitor
AU - Moon, Krystal
AU - Pendaries, Caroline
AU - Volle-Challier, Cecile
AU - Bono, Francoise
AU - Herbert, Jean Marc
AU - Pulecio, Julian
AU - Xia, Yun
AU - Li, Mo
AU - Montserrat, Nuria
AU - Ruiz, Sergio
AU - Dubova, Ilir
AU - Rodriguez, Concepcion
AU - Denli, Ahmet M.
AU - Boscolo, Francesca S.
AU - Thiagarajan, Rathi D.
AU - Gage, Fred H.
AU - Loring, Jeanne F.
AU - Laurent, Louise C.
AU - Izpisua Belmonte, Juan Carlos
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Lineage conversion of one somatic cell type to another is an attractive approach for generating specific human cell types. Lineage conversion can be direct, in the absence of proliferation and multipotent progenitor generation, or indirect, by the generation of expandable multipotent progenitor states. We report the development of a reprogramming methodology in which cells transition through a plastic intermediate state, induced by brief exposure to reprogramming factors, followed by differentiation. We use this approach to convert human fibroblasts to mesodermal progenitor cells, including by non-integrative approaches. These progenitor cells demonstrated bipotent differentiation potential and could generate endothelial and smooth muscle lineages. Differentiated endothelial cells exhibited neo-angiogenesis and anastomosis in vivo. This methodology for indirect lineage conversion to angioblast-like cells adds to the armamentarium of reprogramming approaches aimed at the study and treatment of ischemic pathologies.
AB - Lineage conversion of one somatic cell type to another is an attractive approach for generating specific human cell types. Lineage conversion can be direct, in the absence of proliferation and multipotent progenitor generation, or indirect, by the generation of expandable multipotent progenitor states. We report the development of a reprogramming methodology in which cells transition through a plastic intermediate state, induced by brief exposure to reprogramming factors, followed by differentiation. We use this approach to convert human fibroblasts to mesodermal progenitor cells, including by non-integrative approaches. These progenitor cells demonstrated bipotent differentiation potential and could generate endothelial and smooth muscle lineages. Differentiated endothelial cells exhibited neo-angiogenesis and anastomosis in vivo. This methodology for indirect lineage conversion to angioblast-like cells adds to the armamentarium of reprogramming approaches aimed at the study and treatment of ischemic pathologies.
UR - http://www.scopus.com/inward/record.url?scp=84871977315&partnerID=8YFLogxK
U2 - 10.1038/nmeth.2255
DO - 10.1038/nmeth.2255
M3 - Article
C2 - 23202434
SN - 1548-7091
VL - 10
SP - 77
EP - 83
JO - Nature Methods
JF - Nature Methods
IS - 1
ER -